Lutetium vipivotide tetraxetan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium vipivotide tetraxetan, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer